Epilepsy

Enveric Biosciences Expands Mental Health Patent Portfolio With 5 New Additions

Longboard Pharmaceuticals Boasts High-Value Epilepsy Assets, Analyst Initiates Coverage

UK Mom's Concern As No Doctor Will Prescribe Cannabis For Her Daughter's 300 Daily Seizures

Longboard Pharmaceuticals Boasts High-Value Epilepsy Assets, Analyst Initiates Coverage

UK Mom's Concern As No Doctor Will Prescribe Cannabis For Her Daughter's 300 Daily Seizures

Inhaled Dry Powder CBD For Epileptic Seizures: Receptor Life Sciences' FDA Drug Application

UCB to Buy Epilepsy-Focused Zogenix In $1.9B Deal: See The Highlights

Inhaled Dry Powder CBD For Epileptic Seizures: Receptor Life Sciences' FDA Drug Application

UCB to Buy Epilepsy-Focused Zogenix In $1.9B Deal: See The Highlights

Study Suggests Whole-Plant Medicinal Cannabis Could Be More Effective Than CBD In Epilepsy Treatment

Taysha Gene's Epilepsy Candidate Shows Encouraging Action In Preclinical Studies

Epilepsy Recent News

Stoke Touts Early Signs Of Efficacy For Antisense Drug In Dravet Syndrome

Stoke Therapeutics Inc (NASDAQ: STOK)

Xenon Stock Jumps On New Encouraging Data From Epilepsy Treatment

Xenon Pharmaceuticals Inc (NASDAQ: XENE) announced

Xenon Pharma Shares Jump After Epilepsy Treatment Phase 2 Data Meets Primary Endpoint

Taysha's Rare Epilepsy Gene Therapy Receives European Orphan Drug Tag

UK Competition And Markets Authority Accuses Pfizer Of Illegal Pricing Of Its Epilepsy Drug

Pfizer Inc (NYSE: PFE) and Flynn Pharma Ltd have been accused by the U.K.'s competition watchdog of

Marinus Files US Application For Ganaxolone For Genetic Epilepsy, Inks European Commercialization Pact With Orion

OPKO Health, CAMP4 Therapeutics Ink Oligonucleotide Platform With Focus On Drug-Resistant Epilepsy

Zynerba's Zygel Improves Sleep In Children With Severe Epilepsies

Zogenix's Fintepla Associated With Improvements in Seizure Control, Executive Functions In Childhood Epilepsy Disorder

Ovid Shares Rally On Soticlestat Development Pact With Takeda In Rare Epilepsy Syndromes

Takeda Pharmaceutical Co Ltd (NYSSE: TAK) has agreed to secure global rights from Ovid Therapeutics Inc (NASDAQ: OVID) for soticlestat (TA

How Can Cannabis Help With Epilepsy?

This article was originally published on The Medical Cannabis Community, and appears here with permission.

'Exceeded Our Expectations': First Latin American Study On CBD, Epilepsy Completed

'Renewed Sense Of Hope': GW Pharma CEO Talks Epilepsy Drug Approval In Europe

Zogenix Soars On Positive Phase 3 Data In Dravet Syndrome Study

GW Pharmaceuticals' FDA Win Reinforces BofA's Bullish Thesis

Marinus Pharmaceuticals Has 3 Major Catalysts In 2018, Ladenburg Thalmann Says In Bullish Initiation

'An Incredible Signal': 4 Experts Weigh In On Positive FDA Panel Vote For GW Pharma's Epidiolex

Zynerba Pharmaceuticals Shares Volatile After Epilepsy Study Results

What Do Zogenix Drug Study Results Mean For GW Pharmaceuticals' Epidiolex?

What's The Difference Between Zynerba and GW Pharma's Epilepsy Drugs?

What Analysts Expect For Zynerba's Upcoming Wave Of Data

Pfizer Fined $106 Million For Anti-Epilepsy Drug

Oppenheimer Downgrades Marinus Pharmaceuticals, Removes Price Target On Disappointing Epilepsy Study Results